Stay updated with breaking news from Dennis Lanfear. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
Operator: Good day and thank you for standing by. Welcome to the Coherus Biosciences Third Quarter 2023 Conference Call. At this time all participants are in a listen-only mode.
World-leading cancer treatment becomes first Chinese biopharmaceutical drug to be approved by America’s FDA.
SmithRx, which bills itself as "next-generation pharmacy benefits management," announced that it will offer Yusimry to its members at a discount of more than 90%.